Results 151 to 160 of about 280,067 (169)

High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase–Lowering Effect of a HSD17B13 Variant

Hepatology, 2020
A common loss‐of‐function variant in HSD17B13 (rs72613567:TA) was recently found to protect from chronic liver disease. Whether the variant confers protection from specific risk factors for liver disease is unclear.
H. Gellert-Kristensen   +3 more
semanticscholar   +1 more source

Glutamine synthetase and alanine transaminase expression are decreased in livers of aged vs. young beef cows and GS can be upregulated by 17β-estradiol implants.

Journal of Animal Science, 2015
Aged beef cows (≥ 8 yr of age) produce calves with lower birth and weaning weights. In mammals, aging is associated with reduced hepatic expression of glutamine synthetase (GS) and alanine transaminase (ALT), thus impaired hepatic Gln-Glu cycle function.
E. Miles   +6 more
semanticscholar   +1 more source

Globulin–platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels

Clinical and Experimental Medicine (Testo stampato), 2018
Qiang Li   +4 more
semanticscholar   +1 more source

The significance of De Ritis (aspartate transaminase/alanine transaminase) ratio in predicting pathological outcomes and prognosis in localized prostate cancer patients

International Urology and Nephrology, 2017
Huitao Wang   +10 more
semanticscholar   +1 more source

The De Ritis (aspartate transaminase/alanine transaminase) ratio as a predictor of oncological outcomes in patients after surgery for upper urinary tract urothelial carcinoma

International Urology and Nephrology, 2017
Yang Hyun Cho   +25 more
semanticscholar   +1 more source

PNPLA3 I148M polymorphism is associated with elevated alanine transaminase levels in Mexican Indigenous and Mestizo populations

Molecular Biology Reports, 2014
Elena Larrieta‐Carrasco   +17 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy